Compare RCKT & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RCKT | TYGO |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | 202 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 380.1M |
| IPO Year | N/A | 2021 |
| Metric | RCKT | TYGO |
|---|---|---|
| Price | $3.62 | $4.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $29.73 | $6.00 |
| AVG Volume (30 Days) | ★ 2.0M | 701.1K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.12 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $103,536,000.00 |
| Revenue This Year | N/A | $30.78 |
| Revenue Next Year | $64.28 | $21.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 91.68 |
| 52 Week Low | $2.19 | $0.88 |
| 52 Week High | $6.89 | $5.33 |
| Indicator | RCKT | TYGO |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 48.31 |
| Support Level | $3.32 | $3.24 |
| Resistance Level | $4.08 | $4.33 |
| Average True Range (ATR) | 0.23 | 0.55 |
| MACD | 0.03 | -0.07 |
| Stochastic Oscillator | 48.46 | 17.79 |
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.